Skip to main content
Log in

Seizures during the management of high-grade gliomas: clinical relevance to disease progression

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

This study was performed to evaluate the incidence of seizures with its implications on disease progression and the diagnostic value of post-ictal magnetic resonance images (MRI) during the management of high-grade gliomas (HGGs). A total of 406 consecutive patients with newly diagnosed HGGs were retrospectively reviewed. The incidence of seizures during the management was investigated. In patients who experienced a seizure, the causality between seizures and disease progression was assessed by pre-ictal, post-ictal (<1 month), and follow-up (<3 months) MRI. After a median follow-up of 17.4 months (range 0.1–88.3), seizures developed in 127 patients (31 %). Of the 127 patients, radiological progression at the post-ictal MRI was found in 83 patients (65 %) and the follow-up MRI confirmed progression in 79 patients (62 %). Four other patients (3 %) were shown to be progression-free. Among those without radiological progression at the post-ictal MRI, the follow-up MRI confirmed progression-free in 31 patients (24 %); however, 13 patients (10 %) revealed eventual progression. In the patients with a seizure, absence of preoperative seizures (p = 0.003), <95 % tumor resection (p = 0.001), and pre-ictal Karnofsky Performance Scale score ≤70 (p = 0.025) were significantly associated with disease progression. During the management of HGG, 31 % of patients experienced seizures; of these patients, 72 % harbored progressive disease. The post-ictal MRI is useful for detecting disease progression; however, there are pitfalls. Clinical settings should be considered together for diagnosing disease progression in patients with seizures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. DeAngelis LM (2001) Brain tumors. N Engl J Med 344(2):114–123. doi:10.1056/NEJM200101113440207

    Article  PubMed  CAS  Google Scholar 

  2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:10.1056/NEJMoa043330

    Article  PubMed  CAS  Google Scholar 

  3. Kim YH, Park CK, Cho WH, Kim IA, Moon S, Choe G, Park SH, Kim IH, Kim DG, Jung HW, Lee MM, Bae SH, Cha SH, Kim CY (2011) Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study. J Neurooncol 103(3):503–512. doi:10.1007/s11060-010-0404-5

    Article  PubMed  CAS  Google Scholar 

  4. Chaichana KL, Parker SL, Olivi A, Quinones-Hinojosa A (2009) Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article. J Neurosurg 111(2):282–292. doi:10.3171/2009.2.jns081132

    Article  PubMed  Google Scholar 

  5. Pace A, Bove L, Innocenti P, Pietrangeli A, Carapella CM, Oppido P, Raus L, Occhipinti E, Jandolo B (1998) Epilepsy and gliomas: incidence and treatment in 119 patients. J Exp Clin Cancer Res 17(4):479–482

    PubMed  CAS  Google Scholar 

  6. Hwang SL, Lin CL, Lee KS, Lieu AS, Kuo TH, Chang CZ, Yen CP, Loh JK, Huang TY, Howng SL (2004) Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir (Wien) 146(6):589–594. doi:10.1007/s00701-004-0266-8

    Article  Google Scholar 

  7. Hwang SL, Lieu AS, Kuo TH, Lin CL, Chang CZ, Huang TY, Howng SL (2001) Preoperative and postoperative seizures in patients with astrocytic tumours: analysis of incidence and influencing factors. J Clin Neurosci 8(5):426–429. doi:10.1054/jocn.2000.0825

    Article  PubMed  CAS  Google Scholar 

  8. Telfeian AE, Philips MF, Crino PB, Judy KD (2001) Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme. J Exp Clin Cancer Res 20(1):5–10

    PubMed  CAS  Google Scholar 

  9. Boarini DJ, Beck DW, VanGilder JC (1985) Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 16(3):290–292

    Article  PubMed  CAS  Google Scholar 

  10. Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52(7):717–724

    Article  PubMed  CAS  Google Scholar 

  11. Tandon PN, Mahapatra AK, Khosla A (2001) Epileptic seizures in supratentorial gliomas. Neurol India 49(1):55–59

    PubMed  CAS  Google Scholar 

  12. van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256(9):1519–1526. doi:10.1007/s00415-009-5156-9

    Article  PubMed  Google Scholar 

  13. Finn MA, Blumenthal DT, Salzman KL, Jensen RL (2007) Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol 67(3):246–250. doi:10.1016/j.surneu.2006.04.015

    Article  PubMed  Google Scholar 

  14. Rheims S, Ricard D, van den Bent M, Taillandier L, Bourg V, Desestret V, Cartalat-Carel S, Hermier M, Monjour A, Delattre JY, Sanson M, Honnorat J, Ducray F (2011) Peri-ictal pseudoprogression in patients with brain tumor. Neuro Oncol 13(7):775–782. doi:10.1093/neuonc/nor082

    Article  PubMed  Google Scholar 

  15. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8(7):1277–1280

    PubMed  CAS  Google Scholar 

  16. Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26(13):2192–2197. doi:10.1200/JCO.2007.14.8163

    Article  PubMed  Google Scholar 

  17. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9(5):453–461. doi:10.1016/S1470-2045(08)70125-6

    Article  PubMed  Google Scholar 

  18. Lee JW, Wen PY, Hurwitz S, Black P, Kesari S, Drappatz J, Golby AJ, Wells WM 3rd, Warfield SK, Kikinis R, Bromfield EB (2010) Morphological characteristics of brain tumors causing seizures. Arch Neurol 67(3):336–342. doi:10.1001/archneurol.2010.2

    Article  PubMed  Google Scholar 

  19. Lakomy R, Fadrus P, Slampa P, Svoboda T, Kren L, Lzicarova E, Belanova R, Sikova I, Poprach A, Schneiderova M, Prochazkova M, Sana J, Slaby O, Smrcka M, Vyzula R, Svoboda M (2011) Multimodal treatment of glioblastoma multiforme: results of 86 consecutive patients diagnosed in period 2003–2009. Klin Onkol 24(2):112–120

    PubMed  CAS  Google Scholar 

  20. Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M (2011) Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol 29(31):4175–4180. doi:10.1200/JCO.2010.32.4343

    Article  PubMed  CAS  Google Scholar 

  21. Quan D, Hackney DB, Pruitt AA, Lenkinski RE, Cecil KM (1999) Transient MRI enhancement in a patient with seizures and previously resected glioma: use of MRS. Neurology 53(1):211–213

    Article  PubMed  CAS  Google Scholar 

  22. Bartleson JD, Krecke KN, O’Neill BP, Brown PD (2003) Reversible, strokelike migraine attacks in patients with previous radiation therapy. Neuro Oncol 5(2):121–127. doi:10.1215/S1522-8517-02-00040-6

    PubMed  CAS  Google Scholar 

  23. Black DF, Bartleson JD, Bell ML, Lachance DH (2006) SMART: stroke-like migraine attacks after radiation therapy. Cephalalgia 26(9):1137–1142. doi:10.1111/j.1468-2982.2006.01184.x

    Article  PubMed  CAS  Google Scholar 

  24. Brandes AA, Tosoni A, Spagnolli F, Frezza G, Leonardi M, Calbucci F, Franceschi E (2008) Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro Oncol 10(3):361–367. doi:10.1215/15228517-2008-008

    Article  PubMed  Google Scholar 

  25. Ong B, Bergin P, Heffernan T, Stuckey S (2009) Transient seizure-related MRI abnormalities. J Neuroimaging 19(4):301–310. doi:10.1111/j.1552-6569.2008.00352.x

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (2012R1A1A2003779).

Conflict of interest

  None of the authors has any conflicts of interest to disclose.

Ethics Approval

  Ethics approval was provided by the Institutional Review Board of Seoul National University Hospital (H-1201-017-392) and Seoul National University Bundang Hospital (B-1201-143-106).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chul-Kee Park.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 17 kb)

Supplementary material 2 (TIFF 306 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, YH., Park, CK., Kim, T.M. et al. Seizures during the management of high-grade gliomas: clinical relevance to disease progression. J Neurooncol 113, 101–109 (2013). https://doi.org/10.1007/s11060-013-1094-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-013-1094-6

Keywords

Navigation